Cancer Treatment and Research Communications
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 57.7% | 0.995 | Q2 | 83.7% |
| 2024 | 2.4 | Q3 | 39.0% | 0.971 | Q2 | 83.4% |
| 2023 | — | — | 0.793 | Q2 | 79.5% | |
| 2022 | — | — | 0.674 | Q3 | 75.6% | |
| 2021 | — | — | 0.520 | Q3 | 68.3% | |
| 2020 | — | — | 0.459 | Q3 | 63.7% | |
| 2019 | — | — | 0.256 | Q3 | 47.2% | |
| 2018 | — | — | 0.297 | Q3 | 49.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2468-2942
country
GBcoverage
2016-2026